权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

BLUEADAPT: Reducing climate based health risks in blue environments. Adapting to the climate change impacts on coastal pathogens

BLUEADAPT：减少蓝色环境中基于气候的健康风险。

基本信息

批准号：
10052955
负责人：
金额：
$ 200.73万
依托单位：
UNIVERSITY OF EXETER
依托单位国家：
英国
项目类别：
EU-Funded
财政年份：
2022
资助国家：
英国
起止时间：
2022 至无数据
项目状态：
未结题

来源：
https://gtr.ukri.org/projects?ref=10052955
关键词：
BLUEADAPT Reducing climate based health

项目摘要

BlueAdapt brings together an interdisciplinary team of biologists, climate scientists, economists, epidemiologists, and public health experts to investigate and quantify the future health risks associated with selected coastal pathogens. BlueAdapt will provide tools to assess the impacts of policy responses and communicate the results to a wide audience, including both policymakers and the public. A conceptual framework will be developed around existing models of One Health and Ecological Public Health, to help wider engagement with the complex nature of the issue. Horizons scanning and downscaled climate modelling will feed into lab-based experiments and the development of simulations around how changes in climate variables, interacting with other environmental change, may influence the state of selected microbial pathogens of public health concern in coastal waters. Case studies will illustrate how One Health and Ecological Public Health concepts can be used to generate action and identify potential barriers to adaptation. Health impact assessment and cost-benefit analysis will inform appropriate action. BlueAdapt Innovation Slams and policy workshops will help deliver wider impact from the project including new-to-firm and new-to-market products and services.

BlueAdapt汇集了生物学家，气候科学家，经济学家，流行病学家和公共卫生专家的跨学科团队，调查和量化与选定的沿海病原体相关的未来健康风险。BlueAdapt将提供工具来评估政策应对措施的影响，并将结果传达给包括政策制定者和公众在内的广泛受众。将围绕现有的“一个健康”和“生态公共卫生”模式制定一个概念框架，以帮助更广泛地参与这一问题的复杂性。地平线扫描和缩小尺度的气候建模将为实验室实验提供投入，并围绕气候变量的变化与其他环境变化的相互作用如何影响沿海沃茨中公众健康关切的选定微生物病原体的状况，开展模拟。案例研究将说明如何利用“一个健康”和“生态公共健康”概念来采取行动，并查明适应的潜在障碍。健康影响评估和成本效益分析将为采取适当行动提供信息。BlueAdapt创新大满贯和政策研讨会将有助于该项目产生更广泛的影响，包括新的公司和新的市场产品和服务。